Success Metrics

Clinical Success Rate
100.0%

Based on 13 completed trials

Completion Rate
100%(13/13)
Active Trials
2(11%)
Results Posted
23%(3 trials)

Phase Distribution

Ph not_applicable
10
53%
Ph early_phase_1
2
11%
Ph phase_4
1
5%
Ph phase_2
4
21%
Ph phase_1
2
11%

Phase Distribution

4

Early Stage

4

Mid Stage

1

Late Stage

Phase Distribution19 total trials
Early Phase 1First-in-human
2(10.5%)
Phase 1Safety & dosage
2(10.5%)
Phase 2Efficacy & side effects
4(21.1%)
Phase 4Post-market surveillance
1(5.3%)
N/ANon-phased studies
10(52.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

92.9%

13 of 14 finished

Non-Completion Rate

7.1%

1 ended early

Currently Active

2

trials recruiting

Total Trials

19

all time

Status Distribution
Active(2)
Completed(13)
Terminated(1)
Other(3)

Detailed Status

Completed13
unknown3
Recruiting2
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
19
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (10.5%)
Phase 12 (10.5%)
Phase 24 (21.1%)
Phase 41 (5.3%)
N/A10 (52.6%)

Trials by Status

withdrawn15%
recruiting211%
completed1368%
unknown316%

Recent Activity

Clinical Trials (19)

Showing 19 of 19 trials
NCT06120140Phase 2

Enhanced Dermatological Care to Reduce Rash and Paronychia in Epidermal Growth Factor Receptor (EGRF)-Mutated Non-Small Cell Lung Cancer (NSCLC) Treated First-line With Amivantamab Plus Lazertinib

Recruiting
NCT05853692Not Applicable

Prevention of Oral Mucositis in Head and Neck Cancer.

Recruiting
NCT05085834Early Phase 1

Zinc Effect on Inflammation and Cardiovascular Risk in HIV

Completed
NCT05597137Not Applicable

The Exploration of the Regulatory Effect of Zinc on Intestinal Flora in Healthy Adults

Completed
NCT05527899Phase 2

Zinc Intervention in Elderly for Prevention of Pneumonia

Completed
NCT05096312Phase 4

Effects of Oral Zinc Gluconate Among Acne Vulgaris Patients

Completed
NCT02856269Not Applicable

Zinc Supplementation and Cardiovascular Risk in HIV

Completed
NCT05098678Not Applicable

Zinc Supplementation and Behçet's Syndrome

Completed
NCT04351490Not Applicable

Impact of Zinc and Vitamin D3 Supplementation on the Survival of Aged Patients Infected With COVID-19

Withdrawn
NCT04342728Not Applicable

Coronavirus 2019 (COVID-19)- Using Ascorbic Acid and Zinc Supplementation

Completed
NCT03957720Early Phase 1

The Individual Therapy for Patients With Wilson's Disease

Unknown
NCT02475928Not Applicable

Zinc Supplementation in Cirrhotic Patients

Unknown
NCT01934803Not Applicable

Zinc for HIV Disease Among Alcohol Users - an RCT in the Russia ARCH Cohort

Completed
NCT02951715Not Applicable

Improvement of Tinnitus After Oral Zinc on Patients With Noise-induced Hearing Loss

Completed
NCT01783353Phase 2

Oral Zinc Gluconate as Treatment for Recalcitrant Cutaneous Warts: A Randomized, Double-blind, Placebo-controlled Trial

Completed
NCT01984580Phase 1

Effect of Zinc on Barrett's Metaplasia

Unknown
NCT01576627Not Applicable

Zinc Absorption From Zinc Citrate, Zinc Gluconate and Zinc Oxide

Completed
NCT01309620Phase 2

Zinc Supplementation in Type 2 Diabetics

Completed
NCT00692224Phase 1

Efficacy of Zinc in Reducing Hyperbilirubinemia Among High Risk Neonates - A Double Blind Randomized Trial

Completed

All 19 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
19